Parallel Advisors, LLC Silverback Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	BUY	N/A	106 Added 235.56%	151 $0
Q3 2023 Nov 13, 2023	BUY	N/A	151 New	151 $0
Q1 2023 May 20, 2024	BUY	N/A	45 New	45 $0
Q1 2023 Apr 25, 2023	SELL	N/A	-863 Reduced 95.04%	45 $0
Q2 2022 Aug 01, 2022	BUY	$2.9 - $4.44 $1,429 - $2,188	493 Added 118.8%	908 $4,000
Q1 2021 Apr 23, 2021	BUY	$37.62 - $60.41 $9,405 - $15,102	250 Added 151.52%	415 $18,000
Q4 2020 Feb 02, 2021	BUY	$25.0 - $46.34 $4,125 - $7,646	165 New	165 $8,000

163

62.7M

872K

589K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.